{
    "title": "Preventing Overdoses While in Emergency Departments Act of 2018",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Preventing Overdoses While in \nEmergency Departments Act of 2018''.\n\nSEC. 2. PROGRAM TO SUPPORT EMERGENCY DEPARTMENT DISCHARGE AND CARE \n              COORDINATION FOR DRUG OVERDOSE PATIENTS.\n\n    (a) In General.--The Secretary of Health and Human Services shall \nestablish a program (referred to in this Act as the ``Program'') to \ndevelop protocols for discharging patients who have presented with a \ndrug overdose and enhance the integration and coordination of care and \ntreatment options for individuals with substance use disorder after \ndischarge.\n    (b) Grant Establishment and Participation.--\n            (1) In general.--In carrying out the Program, the Secretary \n        shall award grants on a competitive basis to not more than 20 \n        eligible health care sites described in paragraph (2).\n            (2) Eligible health care sites.--To be eligible for a grant \n        under this section, a health care site shall--\n                    (A) submit an application to the Secretary at such \n                time, in such manner, and containing such information \n                as specified by the Secretary;\n                    (B) have an emergency department;\n                    (C)(i) have a licensed health care professional on \n                site who has a waiver under section 303(g) of the \n                Controlled Substances Act (21 U.S.C. 823(g)) to \n                administer medication-assisted treatment; or\n                    (ii) have a demonstrable plan to hire a full-time \n                licensed health care professional who has a waiver \n                described in clause (i) to administer such treatment on \n                site;\n                    (D) have in place an agreement with a sufficient \n                number and range of entities certified under applicable \n                State and Federal law, such as pursuant to registration \n                or a waiver under section 303(g) of the Controlled \n                Substances Act (21 U.S.C. 823(g)) or certification as \n                described in section 8.2 of title 42 of the Code of \n                Federal Regulations, to provide treatment for substance \n                use disorder such that, in combination, the resulting \n                network of entities with an agreement with the hospital \n                cumulatively are capable of providing services for all \n                evidence-based services for the treatment of substance \n                use disorder, as medically appropriate for the \n                individual involved, including--\n                            (i) medication-assisted treatment;\n                            (ii) withdrawal and detoxification services \n                        that include patient evaluation, stabilization, \n                        and readiness for, and entry into, treatment; \n                        and\n                            (iii) counseling;\n                    (E) deploy on-site recovery coaches to help connect \n                patients with treatment and recovery support programs; \n                and\n                    (F) include the provision of overdose reversal \n                medication in discharge protocols for opioid overdose \n                patients.\n            (3) Preference.--In awarding grants under this section, the \n        Secretary shall give preference to eligible health care sites \n        that meet either or both of the following criteria:\n                    (A) The site is a critical access hospital (as \n                defined in section 1861(mm)(1) of the Social Security \n                Act (42 U.S.C. 1395x(mm)(1))), a low volume hospital \n                (as defined in section 1886(d)(12)(C)(i) of such Act \n                (42 U.S.C. 1395ww(d)(12)(C)(i))), or a sole community \n                hospital (as defined in section 1886(d)(5)(D)(iii) of \n                such Act (42 U.S.C. 1395ww(d)(5)(D)(iii))).\n                    (B) The site is located in a geographic area with \n                an overdose rate higher than the national average, \n                based on the most recent data of the Centers for \n                Disease Control and Prevention.\n            (4) Medication-assisted treatment defined.--For purposes of \n        this section, the term ``medication-assisted treatment'' means \n        the use of medication approved by the Food and Drug \n        Administration in combination with behavioral health services \n        to provide an individualized approach to the treatment of \n        substance use disorders, including opioid use disorder.\n    (c) Period of Grant.--A grant awarded to an eligible health care \nsite under this section shall be for a period of at least 2 years.\n    (d) Grant Uses.--\n            (1) Required uses.--A grant awarded under this section to \n        an eligible health care site shall be used for both of the \n        following purposes:\n                    (A) To establish policies and procedures that \n                address the provision of overdose reversal medication, \n                the administration of medication-assisted treatment to \n                a non-fatal overdose patient in the emergency \n                department, and the subsequent referral to evidence-\n                based treatment upon discharge for patients who have \n                experienced a non-fatal drug overdose.\n                    (B) To develop best practices for treating non-\n                fatal drug overdoses, including with respect to care \n                coordination and integrated care models for long-term \n                treatment and recovery options for individuals who have \n                experienced a non-fatal drug overdose.\n            (2) Additional permissible uses.--A grant awarded under \n        this section to an eligible health care site may be used for \n        any of the following purposes:\n                    (A) To hire emergency department recovery coaches, \n                counselors, therapists, social workers, or other \n                licensed medical professionals specializing in the \n                treatment of substance use disorder.\n                    (B) To establish integrated models of care for \n                individuals who have experienced a non-fatal drug \n                overdose which may include patient assessment, \n                followup, and transportation to treatment facilities.\n                    (C) To provide for options for increasing the \n                availability and access of medication-assisted \n                treatment and other evidence-based treatment for \n                individuals with substance use disorders.\n    (e) Reporting Requirements.--\n            (1) Reports by grantees.--Each eligible health care site \n        awarded a grant under this section shall submit to the \n        Secretary an annual report for each year for which the site has \n        received such grant that includes information on--\n                    (A) the number of individuals treated at the site \n                for non-fatal overdoses in the emergency department;\n                    (B) the number of individuals administered \n                medication-assisted treatment at the site in the \n                emergency department;\n                    (C) the number of individuals referred by the site \n                to other treatment facilities after a non-fatal \n                overdose, the types of such other facilities, and the \n                number of such individuals admitted to such other \n                facilities pursuant to such referrals;\n                    (D) the frequency and number of patient \n                readmissions for non-fatal overdoses and substance \n                abuse disorder;\n                    (E) how the grant funding was used; and\n                    (F) the effectiveness of, and any other relevant \n                additional data regarding, having an onsite health care \n                professional to administer and begin medication-\n                assisted treatment for substance use disorders.\n            (2) Report by secretary.--Not less than one year after the \n        conclusion of the Program, the Secretary shall submit to \n        Congress a report that includes--\n                    (A) findings of the Program;\n                    (B) overall patient outcomes under the Program, \n                such as with respect to hospital readmission;\n                    (C) what percentage of patients treated by a site \n                receiving a grant under this section were readmitted to \n                a hospital for non-fatal or fatal overdose; and\n                    (D) a compilation of voluntary guidelines and best \n                practices from the reports submitted under paragraph \n                (1).\n    (f) Authorization of Appropriations.--There is authorized to be \nappropriated to carry out this Act $50,000,000 for the period of fiscal \nyears 2019 through 2023."
}